top of page

What we learned from TCT 2024

Brian Cole

  • Boston Scientific trial misses endpoint



  • Edwards has positive data for Evoque, early TAVR


  • Inari Medical touts FlowTriever data


  • Elixir Medical reports positive outcomes with drug-eluting implant


  • VivaSure’s PerQSeal demonstrates safety and effectiveness


  • CardiaWave’s ultrasound tech meets primary endpoint


  • MitrAssist’s transthoracic heart valve could improve outcomes


  • Shockwave hits milestone in all-female IVL trial


  • Johnson & Johnson’s Abiomed hits primary endpoint in Impella ECP study


  • Long-term data supports Medtronic’s RDN tech


  • HeartFlow reports positive results for AI plaque analysis


 
 
 

Comentários


bottom of page